US HB3797 | 2019-2020 | 116th Congress
Status
Spectrum: Bipartisan Bill
Status: Engrossed on December 10 2020 - 50% progression, died in committee
Action: 2020-12-18 - Read twice and referred to the Committee on the Judiciary.
Pending: Senate Judiciary Committee
Text: Latest bill text (Engrossed) [PDF]
Status: Engrossed on December 10 2020 - 50% progression, died in committee
Action: 2020-12-18 - Read twice and referred to the Committee on the Judiciary.
Pending: Senate Judiciary Committee
Text: Latest bill text (Engrossed) [PDF]
Summary
Establishes a new, separate registration process to facilitate medical marijuana research. Specifically, it directs the Drug Enforcement Administration to register (1) practitioners to conduct medical marijuana research, and (2) manufacturers and distributors to supply marijuana for such research. Additionally, the Department of Health and Human Services must continue to produce marijuana through the National Institute on Drug Abuse Drug Supply Program and offer to sell immature plants and seeds to researchers until manufacturers and distributors can provide a sufficient supply of marijuana for medical research.
Title
Medical Marijuana Research Act
Sponsors
Rep. Earl Blumenauer [D-OR] | Rep. Andy Harris [R-MD] | Rep. Zoe Lofgren [D-CA] | Rep. Morgan Griffith [R-VA] |
Rep. Rob Bishop [R-UT] | Rep. Debbie Dingell [D-MI] | Rep. Matt Gaetz [R-FL] | Rep. Cathy McMorris Rodgers [R-WA] |
Rep. Chris Stewart [R-UT] | Rep. Eleanor Norton [D-DC] | Rep. Dina Titus [D-NV] | Rep. Barbara Lee [D-CA] |
Rep. Raul Grijalva [D-AZ] | Rep. Luis Correa [D-CA] | Rep. Vicky Hartzler [R-MO] | Rep. Greg Walden [R-OR] |
Rep. Lloyd Smucker [R-PA] | Rep. Earl Carter [R-GA] | Sen. Lisa Rochester [D-DE] | Sen. John Curtis [R-UT] |
Rep. Bryan Steil [R-WI] | Rep. Sean Casten [D-IL] |
History
Date | Chamber | Action |
---|---|---|
2020-12-18 | Senate | Read twice and referred to the Committee on the Judiciary. |
2020-12-10 | Senate | Received in the Senate. |
2020-12-09 | House | Motion to reconsider laid on the table Agreed to without objection. |
2020-12-09 | House | On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H7076-7078) |
2020-12-09 | House | DEBATE - The House proceeded with forty minutes of debate on H.R. 3797. |
2020-12-09 | House | Considered under suspension of the rules. (consideration: CR H7076-7083) |
2020-12-09 | House | Mr. Pallone moved to suspend the rules and pass the bill, as amended. |
2020-12-07 | House | Placed on the Union Calendar, Calendar No. 508. |
2020-12-07 | House | Committee on the Judiciary discharged. |
2020-12-07 | House | Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-619, Part I. |
2020-09-09 | House | Ordered to be Reported (Amended) by Voice Vote. |
2020-09-09 | House | Committee Consideration and Mark-up Session Held. |
2019-08-06 | House | Referred to the Subcommittee on Crime, Terrorism, and Homeland Security. |
2019-07-18 | House | Referred to the Subcommittee on Health. |
2019-07-17 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
2019-07-17 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
2019-07-17 | House | Introduced in House |
Same As/Similar To
SB421 (Related) 2019-02-07 - Read twice and referred to the Committee on Finance.
HB1119 (Related) 2019-03-14 - Referred to the Subcommittee on Health.
HB1119 (Related) 2019-03-14 - Referred to the Subcommittee on Health.
Subjects
Administrative law and regulatory procedures
Alternative treatments
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Drug therapy
Drug trafficking and controlled substances
Food and Drug Administration (FDA)
Health
Health personnel
Licensing and registrations
Medical research
Research administration and funding
Alternative treatments
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Drug therapy
Drug trafficking and controlled substances
Food and Drug Administration (FDA)
Health
Health personnel
Licensing and registrations
Medical research
Research administration and funding